Polymorphic microbes: a new emerging hallmark of cancer

Recognition of the microbiome (and `polymorphic microbes' within them) as a new emerging hallmark of cancer reflects a wide body of rapidly evolving research. Microbes may be directly carcinogenic, impact host immune responses to promote malignancy, and may be key effectors in determining the efficacy of anticancer therapy. Manipulation of the microbiome is showing promise as an opportunity to influence cancer outcomes.

Automated summary

Recognition of the microbiome as an emerging hallmark of cancer highlights its potential impact on cancer development and treatment. Microbes can directly cause cancer, influence host immune responses, and affect the efficacy of anticancer therapies. Manipulation of the microbiome holds promise for influencing cancer outcomes.